Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
5.95
-0.18 (-2.94%)
May 30, 2025, 4:00 PM - Market closed
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $20.82 million as of May 30, 2025. Its market cap has decreased by -72.44% in one year.
Market Cap
20.82M
Enterprise Value
12.41M
1-Year Change
-72.44%
Ranking
Category
Stock Price
$5.95
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $20.82M, a decrease of -76.52%. That is a compound annual growth rate of -30.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 20.82M | -42.84% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |